Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | 2.8 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | n/a | (0.51) | (1.89)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (2.53) | (6.02)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (2.97) | (3.78)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (3.00) | (3.50)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Innovate UK Grant Award to Accelerate ADC Pipeline | 06-Jun-2024 | 07:00 | RNS |
BiVictriX – Full Year Results 2023 | 31-May-2024 | 08:44 | RNS |
Orphan Drug Designation & FDA INTERACT Meeting | 17-Apr-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 12.50p |
Change Today | 0.50p |
% Change | 4.17 % |
52 Week High | 15.90 |
52 Week Low | 10.00 |
Volume | 1,735 |
Shares Issued | 82.53m |
Market Cap | £10.32m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
08:05 | 1,735 @ 11.90p |
You are here: research